BRCA1 mutations and survival in women with ovarian cancer
Whitmore, S.E.
New England Journal of Medicine 336(17): 1254-1255; Author Reply 1256-1257
1997
ISSN/ISBN: 0028-4793 PMID: 9121520 Document Number: 476968
Document emailed within 1 workday
Related Documents
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329Ben David, Y.; Chetrit, A.; Hirsh-Yechezkel, G.; Friedman, E.; Beck, B.D.; Beller, U.; Ben-Baruch, G.; Fishman, A.; Levavi, H.; Lubin, F.; Menczer, J.; Piura, B.; Struewing, J.P.; Modan, B. 2002: Effect of BRCA mutations on the length of survival in epithelial ovarian tumors Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 463-466
Narod, S.A.; Sun, P.; Risch, H.A. 2001: Ovarian cancer, oral contraceptives, and BRCA mutations New England Journal of Medicine 345(23): 1706-1707
Olmos, D.; Castro, E. 2013: BRCA mutations in prostate cancer patients Clinical Advances in Hematology and Oncology: H&o 11(9): 598-599
Grann, V. 1997: Risk of breast cancer in carriers of BRCA gene mutations New England Journal of Medicine 337(11): 788
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
Rybchenko, L.A.; Bychkova, A.M.; Skyban, G.V.; Klymenko, S.V. 2013: Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 18: 253-260
Hirsh-Yechezkel, G.; Chetrit, A.; Lubin, F.; Friedman, E.; Peretz, T.; Gershoni, R.; Rizel, S.; Struewing, J.P.; Modan, B. 2003: Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel Gynecologic Oncology 89(3): 494-498
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Howard-McNatt, M. 2013: Pros and cons of screening for BRCA mutations North Carolina Medical Journal 74(6): 489-490
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Levavi, H.; Sabah, G. 2003: BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers European Journal of Gynaecological Oncology 24(6): 463-466
Menkiszak, J.; Gronwald, J.; Górski, B.; Byrski, T.; Huzarski, T.; Jakubowska, A.; Foszczyńska-Kłoda, M.; Brzosko, M.; Fliciński, J.; Rzepka-Górska, I.; Narod, S.A.; Lubiński, J. 2004: Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2 European Journal of Gynaecological Oncology 25(1): 99-100
Cierniková, S.; Tomka, M.; Kovác, M.; Stevurková, V.; Zajac, V. 2006: Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families Neoplasma 53(2): 97-102
Webb, M.J.; Malkasian, G.D.; Jorgensen, E.O. 1974: Factors influencing ovarian cancer survival after chemotherapy Obstetrics and Gynecology 44(4): 564-570
Taylor, C.G.; Sargent, J.M.; Elgie, A.W.; Williamson, C.J.; Lewandowicz, G.M.; Chappatte, O.; Hill, J.G. 2001: Chemosensitivity testing predicts survival in ovarian cancer European Journal of Gynaecological Oncology 22(4): 278-282
2013: Diabetes drug may improve ovarian cancer survival Mayo Clinic Health Letter 31(6): 4
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Brightwell, R.; Eng, K.; Lele, S. 2017: Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients European Journal of Gynaecological Oncology 38(3): 378-381